1-4 of 4
Ali M Al-Ameri
Close
Sort by
Journal Articles

Retrospective Analysis of the Experience with Rituximab and Methylprednisone In Elderly Patients with CLL

Xavier Badoux, MD, Ali M Al-Ameri, Susan O'Brien, MD, William G. Wierda, MD, PhD, Jan A. Burger, MD, PhD, Stefan Faderl, MD, Zeev Estrov, MD, Susan Lerner, MS, BA, Michael J Keating, MD, Alessandra Ferrajoli, MD
Journal: Blood
Blood (2010) 116 (21): 4636.
https://doi.org/10.1182/blood.V116.21.4636.4636
Published: 2010
Journal Articles

Phase II Study of Dasatinib In Patients with Relapsed Chronic Lymphocytic Leukemia.

Ali M Al-Ameri, MD, Xavier Badoux, MD, Alessandra Ferrajoli, MD, William G. Wierda, MD, PhD, Luis Fayad, MD, Zeev Estrov, MD, Susan Bickel, RN, Michael J Keating, MD, Susan O'Brien
Journal: Blood
Blood (2010) 116 (21): 4488.
https://doi.org/10.1182/blood.V116.21.4488.4488
Published: 2010
Journal Articles

Infectious Events In Patients with Chronic Myeloid Leukemia Treated with Nilotinib as a Front Line Therapy and After Imatinib Failure

Ali M Al-Ameri, MD, Jorge E. Cortes, MD, Hagop Kantarjian, MD, Elizabeth Burton, Alfonso Quintas-Cardama, MD, Elias Jabbour, MD, Xavier Badoux, MD, Susan O'Brien, Gloria Mattiuzzi, MD
Journal: Blood
Blood (2010) 116 (21): 1233.
https://doi.org/10.1182/blood.V116.21.1233.1233
Published: 2010
Journal Articles

Low Risk of Infectious Events in Patients (Pts) with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) Treated with Dasatinib.

Ali M Al -Ameri, MD, Hagop Kantarjian, MD, Elizabeth Burton, Susan O'Brien, MD, Farhad Ravandi, M.D., Gautam Borthakur, MD, Brenda Walker, Mary Bath Rios, Jorge Cortes, MD
Journal: Blood
Blood (2009) 114 (22): 3291.
https://doi.org/10.1182/blood.V114.22.3291.3291
Published: 2009